content

Proteostasis Therapeutics Announces In Vitro Data for PTI-129 as Potential Treatment Candidate for COVID-19

Proteostasis Therapeutics, Inc., a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF), announced results...

LabCorp Launches New COVID-19 Clinical Trial Site to Connect Patients With U.S. Research Trials

LabCorp , a leading global life sciences company that is deeply integrated in guiding patient care, announced that Covance, its drug development business, has...

Lilly Begins World’s First Study of a Potential COVID-19 Antibody Treatment in Humans

Eli Lilly and Company announced patients have been dosed in the world's first study of a potential antibody treatment designed to fight COVID-19. This investigational...

Honeywell Expedites Development and Production of Vital Vaccines and Medical Therapies with Fast Track Automation

Honeywell announced Fast Track Automation, a combination of proprietary technology innovations for the life sciences industry that enables vital vaccines, treatments and therapies to...

Klockner Pentaplast Expands in North America to Support the Pharmaceutical Market

Klöckner Pentaplast, a manufacturer of pharmaceutical barrier packaging films, broke ground on a large expansion at its Klöckner Barrier Film (KBF) facility in central...

Biocair Transports Plasmids For COVID-19 Research in South Africa

Biocair, a global specialist in life sciences logistics, was selected to transport time-critical plasmids from the USA to the Africa Health Research Institute (AHRI)...

Takeda Announces Compelling Data from the Phase 2 Trial of Pevonedistat Plus Azacitidine in Patients with Higher-Risk MDS

Takeda Pharmaceutical Company Limited announced the results of the Phase 2 Pevonedistat-2001 trial will be presented during oral sessions at the virtual 56th American...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read